Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19, An Issue of the Clinics in Laboratory Medicine. The Clinics: Internal Medicine Volume 42-1


Book
February 2022
Elsevier Health Science
ID: 5548670

In this issue of Clinics in Laboratory Medicine, guest editors Drs. Daimon P. Simmons and Peter H. Schur bring their considerable expertise to the topic of Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19. Top experts in the field cover key topics such as performance of central lab assays to detect SARS-COV-2 antibodies; alternative methods to detect SARS-CoV-2 antibodies; the role of antibodies in developing vaccines for COVID-19; SARS-COV-2 antibodies after immunization; and more.

Contains 9 relevant, practice-oriented topics including disease-specific alterations in the cellular bases of the humoral immune response in COVID-19; coronavirus antigens as targets of antibody responses; approaches for SARS-CoV-2 antibody testing in a reference lab; use of IgM, IgA, and IgG in treatment and prognosis of patients with COVID-19; performance of lateral flow assays for COVID-19 serology; and more.
Provides in-depth clinical reviews on detection of SARS-CoV-2 antibodies in diagnosis and treatment of COVID-19, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing - A Laboratory PrimerPerformance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A ReviewPerformance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 SerologyAlternative Methods to Detect Severe Acute Respiratory Syndrome Coronavirus 2 AntibodiesSuboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant GenerationAntibody Dynamics and Durability in Coronavirus Disease-19Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody ResponsesVaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)

Authors

Daimon P. Simmons Instructor in Pathology, Brigham and Women's Hospital and,Harvard Medical School. Peter H. Schur Co-Director, Lupus Center, Professor, Harvard Medical School, Brigham and Women's Hospital.

Table of Contents

Authors

Related Topics

Related Products

Global COVID-19 Diagnostic Market: Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market: Forecasts by Application by Place and by Country, with Market Analysis & Executive Guides

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028

Fc and Glycoengineered Antibodies Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Engineering, Type of Therapy, Therapeutic Area, Route of Administration and Key Geographical Regions

Global Antibody Hit Generation and Screening Market: Analysis and Forecast, 2023-2032